How IP can support investment and funding in biote...
Isobel Finnie, Partner and UK and European patent attorney within the Chemi...
Read MoreThe headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.
Remember:
Get our executive insight into your inbox
Written By
Isobel Finnie
21 November 2017
Isobel Finnie, Partner and UK and European patent attorney within the Chemi...
Read MoreThis is the third in a series of four articles which aim to provide tips fo...
Read MoreThis is the second in a series of four articles which aim to provide tips f...
Read MoreAt the core of any biotech company is an innovative piece of science which ...
Read MoreThis week Biotech and Money released its brochure for the eagerly anticipat...
Read MoreDr Jackie Maguire, Chief Executive of Coller IP, has over 25 years technolo...
Read MoreSimon Portman specialises as a commercial contract lawyer for technology co...
Read MoreThe following panel transcript is Audience Q&A taken from the 4th September...
Read MoreThe following panel transcript is group Q&A taken from the 4th September ‘B...
Read MoreThe Drugs & Dealers Blog provides genuine thought leadership, exclusive executive insight and market intelligence on the life science and healthcare investment sector.
© 2018 All Rights Reserved By Biotech and Money / LSX Limited
Add Your Response